Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib (Q39813821)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib |
scientific article |
Statements
1 reference
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib (English)
1 reference
Ching Ching Leow
1 reference
Jon Chesebrough
1 reference
Karen T Coffman
1 reference
Christine A Fazenbaker
1 reference
John Gooya
1 reference
David Weng
1 reference
Steve Coats
1 reference
Dowdy Jackson
1 reference
Bahija Jallal
1 reference
Yong Chang
1 reference
11 August 2009
1 reference
1 reference
Identifiers
1 reference